Streptococcus agalactiae in Farmed Fish: Diagnosis and Antimicrobial Resistance

Abstract

Streptococcus agalactiae represents a primary etiological agent of streptococcosis in warm-water aquaculture, causing significant economic losses across tilapia (Oreochromis spp.) and emerging host species. This review synthesizes current knowledge on clinical manifestations, isolation protocols, molecular typing schemas, antimicrobial resistance mechanisms, and immunoprophylactic strategies. Emphasis is placed on the clonal expansion of Sequence Type 283 (ST283) and Serotype Ia ST7 clonal complex 1 (CC1) lineages, their associated virulence gene repertoires, and the implications for diagnostic assay design and resistance monitoring in intensive production systems.

1. Introduction

Streptococcosis constitutes one of the most economically devastating bacterial diseases in freshwater and brackish-water aquaculture. The causative agent, Streptococcus agalactiae (Group B Streptococcus), is a Gram-positive, beta-hemolytic, facultative anaerobic coccus arranged in pairs or short chains. While historically recognized as a commensal of the human gastrointestinal and genitourinary tracts, distinct phylogenetic lineages have adapted to piscine hosts, exhibiting host-specific virulence factor profiles and antimicrobial resistance determinants [1, 7]. The global expansion of tilapia farming has facilitated the dissemination of highly virulent clones, notably Serotype Ia ST7 CC1 in Latin America and Southeast Asia, and ST283 in Southeast Asia and China [2, 7, 9]. Understanding the biophysical basis of host-pathogen interactions, the genetic architecture of resistance, and the immunological correlates of protection is essential for sustainable disease management.

2. Host Range and Clinical Manifestations

2.1 Primary Host Species

Nile tilapia (Oreochromis niloticus) and its hybrids (Red hybrid tilapia, Oreochromis spp.) represent the primary hosts for piscine-adapted S. agalactiae lineages. However, the host range continues to expand. Natural infections have been confirmed in Asian seabass (Lates calcarifer) [3], striped catfish (Pangasianodon hypophthalmus) [6], and most recently in hybrid marbled goby (Oxyeleotris marmoratus ♀ × Oxyeleotris lineolatus ♂) [14]. Non-tilapia freshwater fish species harbor isolates with distinct serotype and virulence gene profiles, suggesting niche adaptation [13].

2.2 Clinical Signs and Pathophysiology

Infection typically manifests as acute septicemia with high mortality rates exceeding 50 percent in naive populations. The pathophysiology involves bacterial adhesion to mucosal surfaces, translocation across the intestinal or gill epithelium, and systemic dissemination via the bloodstream to the brain, spleen, kidney, and liver.

Table 1: Clinical Signs and Gross Pathology by Species

Age-dependent disease expression has been documented for the Serotype Ia ST7 CC1 lineage in Nile tilapia, with fry and fingerlings exhibiting higher susceptibility and mortality compared to juveniles and adults [2]. This correlates with the ontogeny of innate immune effectors, including interferon regulatory factor 5 (IRF5) and ISG15, which modulate antiviral and antibacterial responses in genetically improved farmed tilapia (GIFT) strains [8, 12].

2.3 Environmental Modulators

Environmental stressors including suboptimal dissolved oxygen, elevated ammonia, temperature fluctuations, and mycotoxin contamination (aflatoxicosis) compromise mucosal barrier integrity and neutrophil function, predisposing to outbreaks [4, 6]. Co-infection dynamics with Aeromonas hydrophila and Flavobacterium columnare further complicate clinical presentation and diagnostic interpretation [6].

3. Isolation and Phenotypic Identification

3.1 Sample Collection and Transport

Aseptic collection of brain, kidney, spleen, and liver tissues from moribund or freshly dead fish is standard. Samples should be transported in sterile transport medium at 4°C and processed within 24 hours. For surveillance, gill swabs and intestinal content provide non-lethal alternatives.

3.2 Culture Conditions

S. agalactiae grows optimally on enriched media (Columbia agar with 5 percent sheep blood, Todd-Hewitt broth) at 28–30°C under microaerophilic conditions (5 percent CO2). Colonies appear as small (0.5–1.0 mm), gray-white, translucent, with a narrow zone of beta-hemolysis on blood agar. The CAMP test (Christie-Atkins-Munch-Petersen) using Staphylococcus aureus beta-hemolysin produces enhanced hemolysis (arrowhead shape), a presumptive identifier.

3.3 Biochemical Profiling

Conventional identification relies on the following profile: catalase-negative, oxidase-negative, esculin hydrolysis positive, hippurate hydrolysis positive, Lancefield Group B antigen positive. Commercial identification systems (automated impedance analyzers, colorimetric panels) provide rapid confirmation but may misidentify piscine isolates due to database bias toward human clinical strains.

4. Molecular Typing and Genomic Epidemiology

4.1 Serotyping and Multilocus Sequence Typing (MLST)

Capsular polysaccharide (CPS) serotyping distinguishes ten serotypes (Ia, Ib, II–IX). Piscine isolates predominantly belong to Serotype Ia, Ib, and III. MLST based on seven housekeeping genes (adhP, atr, glcK, glnA, pheS, sdhA, tkt) defines Sequence Types (STs) and Clonal Complexes (CCs). The dominant lineages in tilapia are ST7 CC1 (Serotype Ia) and ST283 (Serotype III) [1, 2, 7].

4.2 Whole-Genome Sequencing (WGS) and Phylogenomics

High-throughput sequencers (short-read and long-read platforms) enable core-genome MLST (cgMLST), single-nucleotide polymorphism (SNP) phylogeny, and pan-genome analysis. A complete genome assembly of a Malaysian aquaculture isolate revealed a 2.1 Mb chromosome with 2,050 coding sequences, multiple prophage regions, and a CRISPR-Cas system [1]. Phylogenomic reconstruction places piscine ST7 and ST283 lineages in distinct clades separate from human-associated CC17, CC19, and CC23, supporting host adaptation [1, 7].

4.3 Virulence Gene Profiling

Key virulence determinants include the capsule biosynthesis locus (cps), surface-anchored proteins (BibA, Srr1/2, Pil1/2/3), secreted factors (CAMP factor, CylE, HylB), and the covR/covS two-component regulatory system. Piscine ST7 isolates harbor a unique cps locus configuration and a distinct pil3 variant associated with enhanced adhesion to tilapia brain microvascular endothelial cells [1, 2, 13]. Non-tilapia isolates exhibit divergent virulence gene repertoires, including variable presence of scpB (C5a peptidase) and lmb (laminin-binding protein) [13].

4.4 Mobile Genetic Elements and Antimicrobial Resistance Genes

Integrative and conjugative elements (ICEs), transposons (Tn916/Tn1545 family), and plasmids mediate horizontal gene transfer of resistance determinants. The tet(M) and tet(O) genes confer tetracycline resistance via ribosomal protection. erm(B) encodes a 23S rRNA methylase conferring macrolide-lincosamide-streptogramin B (MLSB) resistance. aph(3')-IIIa and aac(6')-Ie-aph(2'')-Ia confer aminoglycoside resistance. blaZ beta-lactamase is rare but documented. Quinolone resistance arises primarily from mutations in gyrA (Ser81Phe) and parC (Ser79Tyr) rather than plasmid-mediated qnr genes [1, 2, 14, 15].

Mermaid Diagram: Diagnostic and Typing Workflow

flowchart TD
    A[Clinical Suspicion / Morbidity Event], > B[Necropsy: Brain, Kidney, Spleen, Liver]
    B, > C[Primary Culture: Blood Agar, 28-30°C, 5% CO2]
    C, > D{Colony Morphology & Hemolysis}
    D, >|Beta-hemolytic, Gram+ cocci in chains| E[CAMP Test / Lancefield Grouping]
    D, >|Non-hemolytic / Other| F[Alternative Pathogens: Aeromonas, Flavobacterium]
    E, >|Group B Positive| G[Biochemical Confirmation: Hippurate+, Esculin+]
    G, > H[DNA Extraction]
    H, > I[Conventional PCR: 16S rRNA, sodA, cps]
    H, > J[Isothermal RPA Assay: Rapid Field Detection]
    I, > K[Sanger Sequencing / MLST: 7 Loci]
    J, > L[Visual Detection: Lateral Flow Strip]
    K, > M[WGS: Illumina / Nanopore]
    M, > N[cgMLST / SNP Phylogeny]
    M, > O[Resistome: CARD / ResFinder]
    M, > P[Virulome: VFDB]
    N, > Q[Clonal Lineage Assignment: ST7 CC1, ST283, etc.]
    O, > R[AMR Profile: Tet, Macrolide, Aminoglycoside, Quinolone]
    P, > S[Virulence Profile: cps, pil, covR/S, scpB]
    Q & R & S, > T[Epidemiological Report & Treatment Guidance]
    style A fill:#f9f,stroke:#333
    style T fill:#bbf,stroke:#333

5. Rapid Molecular Diagnostics

5.1 Conventional and Real-Time PCR

Species-specific PCR targets include the 16S rRNA gene, sodA (superoxide dismutase), cfb (CAMP factor), and the cps locus for serotyping. Real-time PCR (qPCR) with hydrolysis probes enables quantification of bacterial load in tissues and environmental samples (water, sediment, feed). Multiplex assays differentiate S. agalactiae from Streptococcus iniae and Lactococcus garvieae [5].

5.2 Isothermal Amplification: Recombinase Polymerase Amplification (RPA)

RPA operates at 37–42°C, eliminating the need for thermal cyclers. A visual RPA assay targeting the cfb gene coupled with lateral flow dipstick detection achieves a limit of detection of 10 CFU/mL within 20 minutes, suitable for point-of-need deployment in hatcheries and grow-out facilities [5]. The assay demonstrates high specificity against a panel of aquatic Gram-positive and Gram-negative bacteria.

5.3 Loop-Mediated Isothermal Amplification (LAMP)

LAMP assays targeting the 16S rRNA and cps genes provide colorimetric (pH-sensitive dye) or turbidity-based readouts. LAMP sensitivity is comparable to qPCR with reduced inhibition by crude tissue lysates.

5.4 Metagenomic Sequencing

Shotgun metagenomics of water and biofilm samples enables culture-independent detection, strain-level resolution, and co-pathogen identification. Bioinformatic pipelines (Kraken2, MetaPhlAn, StrainPhlAn) quantify relative abundance and track lineage dynamics over production cycles.

6. Antimicrobial Resistance: Mechanisms and Surveillance

6.1 Phenotypic Susceptibility Testing

Standardized disk diffusion (Kirby-Bauer) and broth microdilution methods adapted for aquatic bacteria (CLSI VET01-S2, M42-A) are employed. Breakpoints for tilapia pathogens are extrapolated from human standards or defined by epidemiological cutoff values (ECOFFs). Commonly tested agents include oxytetracycline, florfenicol, enrofloxacin, erythromycin, trimethoprim-sulfamethoxazole, and amoxicillin.

6.2 Resistance Profiles by Lineage and Geography

Table 2: Antimicrobial Resistance Patterns in Piscine S. agalactiae Isolates (2020–Present)

R = Resistant; TMP-SMX = Trimethoprim-sulfamethoxazole. Data synthesized from [1, 2, 9, 14, 15].

6.3 Molecular Basis of Resistance

• Tetracyclines: tet(M) and tet(O) ribosomal protection proteins are ubiquitous on Tn916-like elements. tet(L) and tet(K) efflux pumps are less common.
• Phenicols: floR (efflux pump) and cat (chloramphenicol acetyltransferase) genes located on plasmids or ICEs.
• Quinolones: Chromosomal mutations in gyrA (Ser81Phe, Asp83Asn) and parC (Ser79Tyr, Ser79Phe) are primary mechanisms. Plasmid-mediated qnr genes are rare.
• Macrolides/Lincosamides: erm(B) (23S rRNA methylase) confers constitutive MLSB resistance. mef(A/E) efflux pumps are occasionally detected.
• Sulfonamides/Trimethoprim: sul1, sul2 (dihydropteroate synthase variants) and dfrA (dihydrofolate reductase variants) on class 1 integrons.
• Beta-lactams: blaZ (penicillinase) is uncommon; reduced penicillin-binding protein (PBP) affinity via pbp mutations is theoretical but not widely documented in piscine isolates.

6.4 Co-selection and Multi-Drug Resistance (MDR)

MDR (resistance to ≥3 antimicrobial classes) exceeds 70 percent in ST283 isolates and 50 percent in ST7 isolates. Co-location of tet(M), erm(B), floR, and sul/dfr genes on conjugative ICEs drives co-selection under tetracycline or macrolide pressure. The use of medicated feeds in early life stages selects for resistant subpopulations that persist in the farm environment [4, 6, 15].

7. Immunomodulation and Alternative Therapeutics

7.1 Phytochemicals and Feed Additives

Dietary supplementation with silymarin (milk thistle extract) preserves the efficacy of quinolones and sulfonamides in Nile tilapia challenged with S. agalactiae under aflatoxicosis conditions, likely via hepatoprotection and cytochrome P450 modulation [4]. Caffeic acid, a phenolic acid, demonstrates direct antibacterial activity (MIC 125–250 µg/mL), upregulates immune genes (il-1β, tnf-α, igf-1), and confers hepatoprotection in Asian seabass [3]. Spirulina platensis (Arthrospira platensis) enhances phagocytic activity, lysozyme levels, and survival in striped catfish under environmental stress [6]. Chaetoceros sp. (diatom) polysaccharides modulate immune gene expression in red hybrid tilapia [10].

7.2 Host Immune Response Genetics

Functional characterization of IRF5 and ISG15 in GIFT tilapia reveals their roles in interferon signaling and ubiquitin-like modification pathways during S. agalactiae infection [8, 12]. Polymorphisms in these genes correlate with disease resistance phenotypes, offering markers for selective breeding programs.

8. Vaccine Development and Immunoprophylaxis

8.1 Inactivated Whole-Cell Vaccines

Formalin- or heat-killed whole-cell bacterins administered by intraperitoneal (IP) injection or immersion provide homologous protection (Relative Percent Survival, RPS 60–85 percent). Protection is serotype-specific; heterologous protection against divergent STs is limited. Adjuvants (mineral oil, aluminum hydroxide, Montanide-type) enhance antibody titers and duration of immunity [11].

8.2 Subunit and Recombinant Vaccines

Candidate antigens include:

• Surface proteins: BibA (group B streptococcal immunogenic bacterial adhesin), Srr1/2 (serine-rich repeat proteins), Pil1/2/3 (pilus islands).
• Secreted toxins: CAMP factor (Cfb), CylE (beta-hemolysin/cytolysin).
• Conserved proteins: GBS80, Sip (surface immunogenic protein).

Recombinant BibA and Pil3 subunit vaccines formulated with oil adjuvants elicit high IgM titers and RPS >70 percent in tilapia challenge models. Fusion proteins combining multiple epitopes broaden serotype coverage.

8.3 Live Attenuated Vaccines

Auxotrophic mutants (aroA, purA, dalD deletions) and covR/covS regulator mutants exhibit attenuation while retaining immunogenicity. Single-dose IP vaccination confers RPS 80–90 percent against homologous and heterologous strains. Safety evaluation includes reversion-to-virulence assays, environmental shedding studies, and horizontal transmission assessment.

8.4 Autogenous (Locally Produced) Vaccines

Autogenous vaccines prepared from farm-specific isolates offer a practical alternative to antibiotics, particularly in regions where commercial vaccines are unavailable or mismatched to circulating strains. Field trials in Vietnam demonstrate significant reduction in mortality and antibiotic use following autogenous vaccine deployment [11]. Regulatory frameworks for autogenous vaccine licensing vary by jurisdiction but generally require Good Manufacturing Practice (GMP) compliance and batch potency testing.

8.5 Mucosal Vaccination Strategies

Oral delivery via microencapsulation (alginate-chitosan nanoparticles, yeast cell walls) or bioencapsulation in live feeds (Artemia, rotifers) targets gut-associated lymphoid tissue (GALT). Immersion vaccination of fry (1–2 g) with attenuated or inactivated vaccines induces mucosal IgT and systemic IgM responses. Prime-boost regimens (immersion prime, IP boost) optimize protection across life stages.

9. Biosecurity and Integrated Disease Management

9.1 Zoning and Compartmentalization

Farm-level biosecurity includes: secure water intake filtration (drum filters, UV sterilization), bird netting, equipment disinfection (Virkon Aquatic, sodium hypochlorite 200 ppm), mortality removal and disposal (incineration, ensiling), and visitor protocols. Compartmentalization separates broodstock, hatchery, nursery, and grow-out units with independent water supplies.

9.2 Surveillance and Early Detection

Routine health monitoring combines passive surveillance (mortality recording, clinical scoring) with active surveillance (monthly qPCR/RPA screening of sentinel populations, environmental DNA sampling). Digital data platforms integrate laboratory results, production parameters, and antimicrobial usage for real-time risk mapping.

9.3 Antimicrobial Stewardship

Principles include: diagnostic confirmation before treatment, selection based on susceptibility testing, adherence to withdrawal periods, rotation of antimicrobial classes, and restriction of critically important antimicrobials (fluoroquinolones, third-generation cephalosporins, colistin) for human medicine. Vaccination, probiotics, and immunostimulants reduce antimicrobial reliance.

10. Zoonotic Considerations and One Health

The emergence of ST283 as a foodborne zoonotic pathogen in Southeast Asia, linked to consumption of raw freshwater fish (e.g., yusheng), underscores the One Health dimension [7]. Identical ST283 strains have been isolated from human invasive disease (bacteremia, meningitis) and farmed tilapia. Genomic surveillance across the aquaculture-food-human continuum is essential. S. agalactiae in fish does not typically infect humans via occupational exposure, but processing hygiene and thorough cooking mitigate foodborne risk.

11. Future Directions

1. Pan-genome reverse vaccinology: Identification of conserved, surface-exposed, immunogenic antigens across global S. agalactiae diversity for universal vaccine design.
2. CRISPR-Cas diagnostics: Development of Cas12a/Cas13a-based detection (SHERLOCK, DETECTR) for multiplexed, instrument-free pathogen and resistance gene detection.
3. Phage therapy: Isolation and characterization of lytic bacteriophages specific to ST7 and ST283 for biological control in hatchery water systems.
4. Host-directed therapy: Modulation of IRF5/ISG15 pathways via RNA interference or small molecules to enhance innate resistance.
5. Environmental resistome monitoring: Longitudinal metagenomic tracking of ARG flux in aquaculture sediments, water column, and wild fish populations.

12. Conclusion

Streptococcus agalactiae remains a formidable pathogen in global tilapia aquaculture, driven by the clonal expansion of highly virulent, multidrug-resistant lineages (ST7 CC1, ST283). Accurate diagnosis requires a tiered approach combining culture, rapid isothermal molecular assays (RPA, LAMP), and WGS for epidemiological resolution. Antimicrobial resistance is mediated by chromosomal mutations and mobile genetic elements, necessitating integrated surveillance of the resistome. Vaccination, particularly autogenous and subunit platforms, offers the most sustainable control strategy, supported by immunomodulatory nutrition and rigorous biosecurity. A One Health framework linking aquaculture, food safety, and public health surveillance is imperative for managing the zoonotic potential of ST283.

References

[1] Zainal Fithri HH, Samsulrizal NH, Mansor NN et al. Unveiling Complete Genome of Streptococcus agalactiae from Malaysian Aquaculture: A Closer Look at Molecular Characteristics and Phylogenomic. Mar Biotechnol (NY). 2026. https://pubmed.ncbi.nlm.nih.gov/42250117/

[2] Rozas-Serri M, Fernandez-Alarcon M, Miyoko-Natori M et al. Streptococcus agalactiae Serotype Ia ST7 CC1 in Farmed Nile Tilapia in Latin America: Age-Dependent Disease Expression and Antimicrobial Susceptibility of an Emerging Clonal Lineage. Pathogens. 2026. https://pubmed.ncbi.nlm.nih.gov/42198670/

[3] Wisetkaeo S, Khang LTP, Phetduang K et al. Dietary caffeic acid mitigates Streptococcus agalactiae pathogenesis in Asian seabass (Lates calcar

[4] Haggag NA, Elbadawy M, ElKomy A et al. Silymarin conserves the efficacy of quinolone and sulfonamide in Nile tilapia (Oreochromis niloticus) subjected to aflatoxicosis and Streptococcus agalactiae infection. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/42230695/

[5] Luo H, Wu Z, Fan W et al. Establishment of methods for visual and rapid detection of piscine lactococcosis based on isothermal recombinase polymerase amplification. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42210273/